Jed Latkin - Net Worth and Insider Trading
Jed Latkin Net Worth
The estimated net worth of Jed Latkin is at least $18 dollars as of 2024-11-13. Jed Latkin is the CEO, COO & CFO of Navidea Biopharmaceuticals Inc and owns about 17,950 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $18. Details can be seen in Jed Latkin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jed Latkin has not made any transactions after 2020-02-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jed Latkin
Jed Latkin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jed Latkin owns 2 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) , and Viper Powersports Inc (VPWI) .
Click here to see the complete history of Jed Latkin’s form 4 insider trades.
Insider Ownership Summary of Jed Latkin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NAVB | Navidea Biopharmaceuticals Inc | 2020-02-20 | Interim COO |
| VPWI | Viper Powersports Inc | 2012-08-23 | director |
Jed Latkin Latest Holdings Summary
Jed Latkin currently owns a total of 1 stock. Jed Latkin owns 17,950 shares of Navidea Biopharmaceuticals Inc (NAVB) as of February 20, 2020, with a value of $18.
Latest Holdings of Jed Latkin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NAVB | Navidea Biopharmaceuticals Inc | 2020-02-20 | 17,950 | 0.00 | 18 |
Holding Weightings of Jed Latkin
Jed Latkin Form 4 Trading Tracker
According to the SEC Form 4 filings, Jed Latkin has made a total of 1 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Navidea Biopharmaceuticals Inc is the acquisition of 5,000 shares on February 20, 2020, which cost Jed Latkin around $5,400.
Insider Trading History of Jed Latkin
- 1
Jed Latkin Trading Performance
GuruFocus tracks the stock performance after each of Jed Latkin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jed Latkin is -32.1%. GuruFocus also compares Jed Latkin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jed Latkin within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jed Latkin's insider trading performs compared to the benchmark.
Performance of Jed Latkin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25.2 | | | | | |
| Relative Return to S&P 500(%) | -21.63 | | | | | |
Jed Latkin Ownership Network
Ownership Network List of Jed Latkin
Ownership Network Relation of Jed Latkin
Jed Latkin Owned Company Details
What does Navidea Biopharmaceuticals Inc do?
Who are the key executives at Navidea Biopharmaceuticals Inc?
Jed Latkin is the Interim COO of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .
Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Navidea Biopharmaceuticals Inc Insider Transactions
Jed Latkin Mailing Address
Above is the net worth, insider trading, and ownership report for Jed Latkin. You might contact Jed Latkin via mailing address: 152 W. 57th Street, 4th Floor, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
